What is he best known for?
The fields of study he is best known for:
Carlo Rivolta focuses on Genetics, Gene, Retinitis pigmentosa, Mutation and Allele.
Many of his studies involve connections with topics such as Waist–hip ratio and Genetics.
His Minimal genome and Genome study in the realm of Gene interacts with subjects such as Bacillus subtilis.
His Minimal genome research is multidisciplinary, relying on both Organism, Gene density, Archaea and Horizontal gene transfer.
His work on Gene family as part of general Genome research is often related to Prophage, thus linking different fields of science.
His study focuses on the intersection of Retinitis pigmentosa and fields such as Missense mutation with connections in the field of Frameshift mutation.
His most cited work include:
- The complete genome sequence of the Gram-positive bacterium Bacillus subtilis (3335 citations)
- Hundreds of variants clustered in genomic loci and biological pathways affect human height (1614 citations)
- Essential Bacillus subtilis genes (1150 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Genetics, Retinitis pigmentosa, Gene, Retinal degeneration and Mutation.
His studies in Allele, Missense mutation, Exome sequencing, Genome and PRPF31 are all subfields of Genetics research.
His research on Genome frequently connects to adjacent areas such as Genome-wide association study.
His Gene study frequently involves adjacent topics like Disease.
His Retinal degeneration research incorporates themes from Sensorineural hearing loss and Molecular biology.
His Mutation study combines topics in areas such as Genetic heterogeneity and Haplotype.
He most often published in these fields:
- Genetics (75.36%)
- Retinitis pigmentosa (39.81%)
- Gene (38.86%)
What were the highlights of his more recent work (between 2018-2021)?
- Genetics (75.36%)
- Gene (38.86%)
- Retinitis pigmentosa (39.81%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Genetics, Gene, Retinitis pigmentosa, Phenotype and Retinal degeneration.
His studies link Retinal with Genetics.
His Gene study often links to related topics such as Cell biology.
Carlo Rivolta focuses mostly in the field of Retinitis pigmentosa, narrowing it down to topics relating to Macular dystrophy and, in certain cases, Nonsense mutation, Cohort and Age of onset.
His Phenotype study deals with Disease intersecting with Bioinformatics.
His Genome research is multidisciplinary, incorporating elements of Leiden Open Variation Database, Genome-wide association study and genomic DNA.
Between 2018 and 2021, his most popular works were:
- Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases (25 citations)
- Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases (25 citations)
- Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration. (18 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Gene, Genetics, Phenotype, Retinitis pigmentosa and Retinal degeneration.
His Gene study combines topics from a wide range of disciplines, such as Retinal and Cell biology.
His study in Mendelian inheritance, Genotype, Allele, Mutation and Sanger sequencing falls within the category of Genetics.
His study in Allele is interdisciplinary in nature, drawing from both Exome sequencing and Heredity.
His work investigates the relationship between Retinitis pigmentosa and topics such as Dystrophy that intersect with problems in Missense mutation, Compound heterozygosity, Frameshift mutation, Nonsense mutation and Cohort.
His biological study spans a wide range of topics, including Endocrinology, Taurine transporter, Membrane transport protein, Transporter and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
